Full-Time
Director – Retail Sales Bioscience
Retail Sales, Biosciences
Posted on 9/5/2025
Mosaic
1,001-5,000 employees
Global producer of crop nutrients
Compensation Overview
$150k - $250k/yr
Company Does Not Provide H1B Sponsorship
Durham, NC, USA
Remote
Candidates must be based in the US.
 Retail (1) |
|---|
- Bachelor's degree required with major in Business Administration or Ag related field
- Master's degree preferred
- 10 years experience
- Strategy Development
- Risk Management
- Product Life Cycle Management
- Staff Development
- Marketing
- Sales Management
- Commercial Experience
- Forecasting
- Proficient in Microsoft Office
- Strong Retail business acumen of commercial and production options and long-term implications
- Strong verbal and written communication skills, including excellent presentation and facilitation skills
- Ability to create effective partnerships at all levels of the organization
- Ability to coach and develop employees at all levels
- Demonstrated leadership skills with emphasis on developing high performance teams
- Demonstrated problem solving techniques
- Proven strategic planning, leadership, and project management capabilities
- Strong interpersonal skills; ability to lead through influence and network
- Demonstrated critical thinking and decision-making skills
- Ability to resolve complex issues and handle multiple priorities
- Ability to travel throughout the US and Canada (50% or more) is expected
- Lead and manage the MBNA Retail Sales Managers and Retail Sales Specialists
- Provide clear direction, coaching, and performance feedback to ensure alignment with business goals
- Foster a high-performance culture focused on customer success and sales growth
- Support employee development and succession planning
- Coordinate and create alignment between Mosaic agronomy services, research/development, marketing, sales, product line, etc.
- Increase sales of Mosaic’s Bioscience products including Powercoat and Biopath and maintain Microessential sales to achieve stretch profitability goals and differentiate Mosaic in the market
- Provide work direction to the team, as well as timely and constructive feedback to ensure employees have a clear understanding of their work, roles, business goals and performance standards
- Manage performance issues when necessary
- Develop and coach employees to retain and grow organizational talent
- Support employees in their career development
- Partner with the Director of Global Product Management – Biosciences and the Director of MBNA Sales to execute the annual North American Bioscience product sales and marketing plans
- Collaborate with Agronomy, Marketing and other functional areas to determine our 'go to market' strategy by NA region and to guide our selective retail strategy to maximize market penetration while stewarding value
- Provide field-level insights to support pricing, segmentation, and value delivery decisions led by Product Management
- Evaluate with Director of Global Product Management – Biosciences, Director MBNA Sales, and Commercial leadership pricing and value share, and implement price increases as needed to achieve fair pricing for our products to achieve our sales and financial targets
- Assist the Director of Global Product Management – Biosciences with the customer segmentation for Bioscience products in North America based on current market trends
- Strengthen Mosaic’s presence in the North American Biosciences market by building relationships with key retail partners and growers
- Organize and participate in promotional and technical events, including trade shows, customer meetings, and training sessions
- Manage Retail Sales budgets to meet performance targets
- Oversee forecasting and customer data transfer with the Retailer Sales team to support sales planning
- Identify and implement best practices to improve communication and sales enablement to enhance market impact
- Master's degree preferred
Mosaic supplies crop nutrients and fertilizers to farmers worldwide. Its products are formulated to meet crop nutrient needs, helping fields grow with better yields by delivering essential nutrients through fertilizers and other soil amendments. The company operates in North and South America, employs over 13,000 people across six countries, and distributes products globally. Mosaic differentiates itself by focusing on sustainability and corporate citizenship, seeking to maximize efficiency and minimize environmental impact while maintaining transparent, ethical practices and strong ESG performance to build trust with customers and communities. The company’s goal is to support global food production by providing reliable, responsible fertilizer solutions that boost productivity while reducing environmental footprint.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Tampa, Florida
Founded
2004
Simplify's Take
What believers are saying
- Biosciences division doubled to $68M revenue in 2025, expanding higher-margin products.
- Record mining output and $100M additional cost savings target improve operational leverage.
- Production expansion to 7M phosphate and 9M potash tonnes supports long-term demand.
What critics are saying
- Phosphate gross margins collapsed to $2 per tonne from $111 in Q1 2026.
- China's Sinochem expands domestic capacity to 25M tonnes by 2028, dumping prices.
- Brazil Araxá idling charges $442M; potential Cade antitrust block locks impairments.
What makes Mosaic unique
- SugaROx T6P biostimulant investment positions Mosaic in high-margin crop biotech adjacencies.
- Uberaba rare earth oxides project monetizes phosphogypsum waste streams by 2030.
- Saudi Arabia joint venture provides low-cost phosphate production near Asian croplands.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
401(k) Retirement Plan
Paid Vacation
Paid Sick Leave
Health Savings Account/Flexible Spending Account
Tuition Reimbursement
Company News
SugaROx, a crop biotechnology spin-out from Rothamsted Research and University of Oxford, has secured £2.5 million in strategic investment from The Mosaic Company. The funding will support international field trials, regulatory activities and commercial scale-up of the company's biostimulant based on trehalose-6-phosphate (T6P). T6P is a naturally occurring signalling molecule that regulates carbon allocation in plants. SugaROx has developed proprietary delivery technologies enabling these molecules to be applied through conventional agricultural spray systems. The products aim to improve crop yield, resilience and nutrient use efficiency. The investment is part of SugaROx's Series A round. The company plans to expand field evaluation programmes across multiple crops and environments, with commercial launches planned for the UK, Europe and North America between 2027 and 2030.
Mosaic Company announced it will idle its Araxá Mining and Chemical Complex and related mining activities at the Patrocínio Complex in Brazil as part of cost-reduction efforts. The company plans to pursue the sale of Araxá assets whilst continuing niobium development at Patrocínio. The idling will reduce annual phosphate production by approximately one million tonnes. Following a potential sale, Mosaic expects annual capital expenditure to decline by $20 to $30 million and operating expenses by $70 to $80 million. The company anticipates recording a pre-tax book impact of $350 to $400 million in the first quarter of 2026, including asset impairments and severance costs. The decision reflects Mosaic's focus on capital allocation discipline, according to CEO Bruce Bodine. Workforce reductions will occur at both sites.
5 Stock Market Casualties You Can't Ignore Today. Published on march 20, 2026 at 8:46 pm by angelica ballesteros in news. Page 1 of 5 In this article, we will look at the 5 Stock Market Casualties You Can't Ignore Today. For a deeper discussion and an extended list, please see 10 Stock Market Casualties You Can't Ignore Today. 5. The Mosaic Company (NYSE:MOS) $23.60-9.92%. The Mosaic Company fell for a third day on Friday, slashing 9.96 percent to close at $23.59 apiece, as investors took path from Bank of America's (BofA) downgraded rating for its stock amid the impact of the ongoing tensions in the Middle East. In a market note, BofA turned neutral for The Mosaic Company (NYSE:MOS), after issuing a "buy" recommendation previously, citing inflation in raw materials due to the Iran war. While BofA remains bullish about the phosphates market, with prices expected to remain elevated over time, the war in the Middle East could cause inflationary pressures on sulfur and ammonia, which could dent The Mosaic Company's (NYSE:MOS) earnings growth and cash flow moving forward. In other news, The Mosaic Company (NYSE:MOS) earlier this month announced efforts to ramp up expansion into rare earths production with its planned development of the Uberaba mine site in Brazil. The initiative will be made through its subsidiary, Mosaic Fertilizantes P&K Limitada, in partnership with Rainbow Rare Earths Ltd. The two parties have already completed an economic assessment for the site, which indicated a processing potential of 2.7 million tons of phosphogypsum per year; 1,900 tons of separated neodymium and praseodymium oxide; and 600 tons of a samarium, europium, and gadolinium product rich in medium and heavy rare earth elements. Page 1 of 5 Related Insider Monkey Articles
The Mosaic Company has affirmed a quarterly dividend of $0.22 per share and announced plans to jointly develop the Uberaba rare earths project in Brazil with Rainbow Rare Earths, targeting rare earth oxide production from phosphogypsum by 2030. Whilst the rare earths partnership could modestly diversify future earnings, Mosaic's business remains anchored in phosphate and potash, where fertilizer pricing and environmental costs are the primary near-term drivers. The project aims to extract additional value from existing phosphate assets, though meaningful contributions remain years away. Analysts project Mosaic will reach $13.1 billion in revenue and $851.3 million in earnings by 2028, requiring 5.2% annual revenue growth. Some optimistic forecasts estimate $14.4 billion in revenue and $1.1 billion in earnings by 2028.
DOJ launches investigation into fertilizer price fixing. Corn farmers across the nation welcomed news this week that the U.S. Department of Justice (DOJ) is actively investigating whether several of the country's largest fertilizer producers colluded to raise prices on American farmers. According to a Bloomberg report, the DOJ's Antitrust Division is examining the pricing practices of Nutrien, Mosaic, CF Industries, Koch, and Yara International for potential civil and criminal violations. Together, these companies control the overwhelming majority of nitrogen, phosphate, and potash fertilizer sold in the United States. The investigation is a significant development for farm families who have been sounding the alarm on fertilizer market concentration for years. In recent months, that call has grown louder. USDA Deputy Secretary Stephen Vaden publicly called Nutrien and Mosaic a "duopoly" earlier this year, and state corn grower organizations - including TCPA and the Iowa Corn Growers Association - have pressed the Attorney General directly for transparency on the department's progress in holding these companies accountable. "We are grateful to see this step forward," Hunt said. "Farmers across this country have been dealing with artificially inflated input costs for far too long, and an investigation will send a clear signal that those days may be numbered. Our farm families deserve a fair and competitive marketplace, and we are encouraged by the reports that the DOJ is working to deliver one." For Texas farmers heading into another planting season with razor-thin margins, this investigation represents a meaningful step forward. While commodity prices have softened, the cost of the nutrients essential to growing a crop has remained stubbornly and artificially high. That squeeze threatens not just individual farm operations, but the long-term stability of its domestic food supply. TCPA will continue to monitor the progress of this investigation and advocate for the fair, competitive marketplace that America's farm families deserve.